Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

568 results

Update on the regulation of high-risk medical devices: a transatlantic perspective

25 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to get an update on new developments in the regulation of high-risk medical devices in Europe and the USA and to learn about opportunities for physicians to become more involved in the regulatory environment.

This session was originally presented during PCR...

Update on the regulation of high-risk medical devices

Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent

25 Jun 2020 – From PCR e-Course 2020

Watch this session if you want to review the Firehawk family TES technology and early clinical outcomes in the treatment of atherosclerotic lesions, to gain the first sight of the 3-year results of the TARGET AC trial and to look into the Future Directions of Target...

Target all comers outcomes update

Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?

25 Jun 2020 – From PCR e-Course 2020

Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.

Videos included on this page: the abstract presentation and an Investigator Perspective.

Paclitaxel DEB for coronary lesions: 12-month results of the PREVAIL study

Last frontiers in treatment of high bleeding risk patients

Watch this session if you want to learn from experts the complexity of HBR patients, to discover newest data on DAPT in this population and to get a first-hand update on upcoming major development in DAPT for HBR patients.

Speaker: Davide Capodanno

This interview supported by Terumo was...

Last frontiers in treatment of high bleeding risk patients

Evaluation of PP-ZES vs. PF-AES Stents in PCI: Latest insights from the ReCre8 randomised trial

Watch this interview if you want to understand how strongly safety & efficacy are interconnected in high bleeding risk patients (very complex patients) and how a Safe DES able to have superior Efficacy would optimize the outcome in HBR patients.

Speakers: Gennaro Sardella, Pieter Stella

This interview supported...

Latest insights from the ReCre8 randomised trial

The new paradigm for coronary interventions

Watch this session to understand indications for DEB vs. DES & the potential advantage of a sustained sirolimus release when utilised in a DEB, and to get insights into the breakthrough technology of SELUTION SLR & its initial clinical data & clinical experience.

Speakers: Stephan Windecker, Robert...

The new paradigm for coronary interventions

First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold: 9- and 24-month imaging and clinical results of the RENASCENT II trial

18 Jun 2020

The novel sirolimus-eluting ultra-high molecular weight APTITUDE bioreabsorbable vascular scaffold (BRS) displays higher mechanical strength, expansion capabilities and resistance to fracture compared to other BRS technologies. RENASCENT II is a prospective, multicentre first-in-human clinical study evaluating the clinical performance of the APTITUDE BRS in the treatment...

Authors :

A. Chieffo, S. A. Khawaja, A. Latib, B. Vesga, M. Moncada, J. A. Delgado, J. Fonseca, L. Testa, G. Esposito, M. Ferrone, B. Cortese, A. Maehara, J. F. Granada, A. Colombo
EuroIntervention: First-in-human evaluation of a novel sirolimus-eluting ultra-high molecular weight APTITUDE bioresorbable scaffold

How to treat ostial lesions with Szabo’s technique?

28 May 2020

Szabo’s technique, also known as “tail-wire” technique, is one of the few specific ostial intervention techniques that can be helpful to achieve precise coverage of the ostium without excessive protrusion into the aorta or the respective main vessel... Discover the tips and solutions proposed by Felix...

Felix Damas De Los Santos

Author

Felix Damas De Los Santos
Julio I. Farjat Pasos

Author

Julio I. Farjat Pasos
Marco A. Peña Cabral

Author

Marco A. Peña Cabral
Eduardo A. Arias Sánchez

Author

Eduardo Arias
My toolkit: How to treat ostial lesions with Szabo’s technique?

How to use a guide-extension catheter for stent delivery

15 May 2020

Population ageing is increasing. Therefore extensive coronary artery calcification is a frequent finding and results in complex coronary interventions. Despite the improvement of stent- and balloon- profile, delivery can be challenging due to vessel tortuosity and calcified plaque... Discover the tips and solutions proposed by Lucas...

Author

Lucas Joerg
Johannes Rigger

Author

Johannes Rigger
My toolkit: How to use a guide-extension catheter for stent delivery

Impact of kissing balloon in patients treated with ultrathin stents for left main lesions and bifurcations: an analysis from the RAIN-CARDIOGROUP VII study

26 Mar 2020

The objective of this analysis was to investigate the potential benefits of FKI in bifurcations treated with new generation ultrathin stents using a 1- or 2-stent technique.

Reviewer

Ali Nazmi Calik
Panagiotis Xaplanteris

Reviewer

Panagiotis Xaplanteris
Impact of kissing balloon in patients treated with ultrathin stents for left main lesions and bifurcations: an analysis from the RAIN-CARDIOGROUP VII study